Open | - |
Close | - |
Volume / Avg. | 108.000 / 215.896K |
Day Range | - - - |
52 Wk Range | 1.850 - 6.600 |
Market Cap | $47.890M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 7.25% |
Days to Cover | 8.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Other companies in Ocuphire Pharma’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Lipocine (NASDAQ:LPCN).
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 20.00 expecting OCUP to rise to within 12 months (a possible 936.27% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $1.93 last updated Today at March 19, 2024 at 5:18 AM EDT.
There are no upcoming dividends for Ocuphire Pharma.
Ocuphire Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Ocuphire Pharma.
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.